Pediapharm Begins Trading on the OTCQB Venture Market

Pediapharm (TSXV:PDP) is pleased to announce the Company’s common shares begin trading today on the OTCQB Venture Market in the United States under the symbol “PDDPF”.
As quoted in the press release:

“Getting listed on the OTCQB is part of our strategy to introduce Pediapharm to a wider audience,” stated Sylvain Chretien, President and Chief Executive Officer of Pediapharm. “These are very exciting times at Pediapharm with the successful commercial launches of Rupall and Otixal in the last 12 months as well as the recently approved Cuvposa to be launched within the next few months. We look forward to share our tremendous growth story with US investors.”

Click here to read the full press release.